Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Lung Cancer-derived Fibroblasts on Mast Cells Activation

NCT02161523 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.

NCT NCT02161523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02161523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Lung Cancer-derived Fibroblasts on Mast Cells Activation
Lead sponsor
Meir Medical Center
Phase
Observational
Overall status
Completed
Start date
July 1, 2014
Completion date
June 1, 2015
Enrollment
20 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer